Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TEF
3001
DELISTED
Telefonica
TEF
| $6.96M | ﹤0.01% |
1,940,219
+1,623,948
| +513% | +$5.49M |
|
|
MAAC
3002
DELISTED
Montes Archimedes Acquisition Corp. Class A Common Stock
MAAC
| $6.96M | ﹤0.01% |
+684,198
| New | +$6.89M |
|
3003
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.4B
| $6.95M | ﹤0.01% |
71,938
+27,971
| +64% | +$2.52M |
|
3004
CALL
Hyatt Hotels
H
$17.1B
| $6.95M | ﹤0.01% |
93,600
+37,400
| +67% | +$2.44M |
|
3005
Halozyme
HALO
$11.2B
| $6.95M | ﹤0.01% |
162,627
-42,773
| -21% | -$1.54M |
|
3006
PUT
GoPro
GPRO
$110M
| $6.94M | ﹤0.01% |
838,200
+152,000
| +22% | +$1.1M |
|
|
BFX
3007
CALL
DELISTED
BowFlex Inc.
BFX
| $6.94M | ﹤0.01% |
382,600
+219,500
| +135% | +$4.57M |
|
3008
CALL
DXC Technology
DXC
$1.72B
| $6.93M | ﹤0.01% |
269,300
-72,000
| -21% | -$1.54M |
|
3009
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$629M
| $6.93M | ﹤0.01% |
3,449
+1,379
| +67% | +$2.2M |
|
3010
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $6.93M | ﹤0.01% |
138,245
+40,481
| +41% | +$1.9M |
|
3011
iShares US Transportation ETF
IYT
$2.28B
| $6.92M | ﹤0.01% |
+125,492
| New | +$6.7M |
|
3012
PUT
Aurinia Pharmaceuticals
AUPH
$2.06B
| $6.91M | ﹤0.01% |
499,900
+349,400
| +232% | +$5.09M |
|
|
APHA
3013
CALL
DELISTED
Aphria Inc. Common Shares
APHA
| $6.91M | ﹤0.01% |
998,400
+316,800
| +46% | +$1.98M |
|
3014
Ichor Holdings
ICHR
$2.66B
| $6.9M | ﹤0.01% |
229,004
+136,364
| +147% | +$3.86M |
|
3015
CALL
Iridium Communications
IRDM
$5.32B
| $6.89M | ﹤0.01% |
175,300
-9,800
| -5% | -$308K |
|
3016
CALL
Pacific Biosciences
PACB
$357M
| $6.88M | ﹤0.01% |
265,300
+194,500
| +275% | +$3.31M |
|
|
AZPN
3017
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $6.88M | ﹤0.01% |
52,790
-76,947
| -59% | -$10M |
|
3018
Protagonist Therapeutics
PTGX
$10B
| $6.87M | ﹤0.01% |
+340,822
| New | +$7.34M |
|
|
EPAY
3019
DELISTED
Bottomline Technologies Inc
EPAY
| $6.86M | ﹤0.01% |
130,121
+47,445
| +57% | +$2.16M |
|
3020
Intercontinental Exchange
ICE
$86.9B
| $6.86M | ﹤0.01% |
59,497
-275,177
| -82% | -$28.6M |
|
|
COHR
3021
CALL
DELISTED
Coherent Inc
COHR
| $6.86M | ﹤0.01% |
45,700
+14,900
| +48% | +$1.91M |
|
3022
CALL
Nano X Imaging
NNOX
$74.1M
| $6.85M | ﹤0.01% |
150,000
+108,500
| +261% | +$4.42M |
|
3023
Boise Cascade
BCC
$2.9B
| $6.84M | ﹤0.01% |
143,199
+77,565
| +118% | +$3.37M |
|
3024
Coca-Cola Europacific Partners
CCEP
$47.6B
| $6.84M | ﹤0.01% |
137,371
-3,314,937
| -96% | -$140M |
|
|
MRSH
3025
CALL
Marsh
MRSH
$89.6B
| $6.84M | ﹤0.01% |
58,500
-1,100
| -2% | -$125K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.